Impact of deep muscle invasion on nodal status and survival in patients with pT2 esophageal squamous cancer

被引:0
|
作者
Yan, Cheng-Yi [1 ,2 ]
Gu, Yi-Min [1 ]
Shi, Gui-Dong [3 ]
Shang, Qi-Xin [1 ]
Zhang, Han-Lu [1 ]
Yang, Yu-Shang [1 ]
Wang, Wen-Ping [1 ]
Yuan, Yong [1 ]
Chen, Long-Qi [1 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Thorac Surg, 37 Guoxue Alley, Chengdu 610041, Sichuan, Peoples R China
[2] Univ South China, Changsha Cent Hosp, Dept Cardiothorac Surg, Changsha, Hunan, Peoples R China
[3] North Sichuan Med Coll, Affiliated Hosp, Dept Cardiothorac Surg, Nanchong, Sichuan, Peoples R China
关键词
depth of muscularis propria invasion; esophageal squamous cell carcinoma; lymph node metastasis; subclassification; survival; METASTASIS; CHINA;
D O I
10.1002/jso.27593
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Whether T2 esophageal squamous cell carcinoma should be subclassified remains controversial. We aimed to investigate the impact of the depth of muscularis propria invasion on nodal status and survival outcomes. Methods: We identified patients with pT2 esophageal squamous cell carcinoma who underwent primary surgery from January 2009 to June 2017. Clinical data were extracted from prospectively maintained databases. Tumor muscularis propria invasion was stratified into superficial or deep. Binary logistic regression was used to determine risk factors for lymph node metastases. The impact of the depth of muscularis propria invasion on survival was investigated using Kaplan-Meier analysis and a Cox proportional hazard regression model. Results: A total of 750 patients from three institutes were investigated. The depth of muscularis propria invasion (odds ratio [OR]: 3.95, 95% confidence interval [CI]: 2.46-6.35; p < 0.001) was correlated with lymph node metastases using logistic regression. T substage (hazard ratio [HR]: 1.37, 95% CI: 1.05-1.79; p < 0.001) and N status (HR: 1.51, 95% CI: 1.05-2.17; p < 0.001) were independent risk factors in multivariate Cox regression analysis. The deep muscle invasion was associated with worse overall survival (HR: 1.52, 95% CI: 1.19-1.94; p = 0.001) than superficial, specifically in T2N0 patients (HR: 1.38, 95% CI: 1.08-1.94; p = 0.035). Conclusions: We found that deep muscle invasion was associated with significantly worse outcomes and recommended the substaging of pT2 esophageal squamous cell carcinoma in routine pathological examination.
引用
收藏
页码:1056 / 1062
页数:7
相关论文
共 50 条
  • [21] PT2 penile squamous cell carcinomas (SCC) - Cavernosus vs. spongiosus invasion
    Rees, R. W.
    Freeman, A.
    Borley, N.
    Ralph, D. J.
    Minhas, S.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 111 - 111
  • [22] Retrospective analysis of survival in muscle-invasive bladder cancer: impact of pT classification, node status, lymphovascular invasion, and neoadjuvant chemotherapy
    D'Souza, Amber M.
    Pohar, Kamal S.
    Arif, Tahir
    Geyer, Susan
    Zynger, Debra L.
    VIRCHOWS ARCHIV, 2012, 461 (04) : 467 - 474
  • [23] Retrospective analysis of survival in muscle-invasive bladder cancer: impact of pT classification, node status, lymphovascular invasion, and neoadjuvant chemotherapy
    Amber M. D’Souza
    Kamal S. Pohar
    Tahir Arif
    Susan Geyer
    Debra L. Zynger
    Virchows Archiv, 2012, 461 : 467 - 474
  • [24] The impact of squamous histology on survival in patients with muscle-invasive bladder cancer
    Matulay, Justin T.
    Woldu, Solomon L.
    Lim, Amy
    Narayan, Vikram M.
    Li, Gen
    Kamat, Ashish M.
    Anderson, Christopher B.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (06) : 353.e17 - 353.e24
  • [25] Radical resection improves survival for patients with pT2 gallbladder carcinoma
    Wise, PE
    Shi, YY
    Washington, MK
    Chapman, WC
    Wright, JK
    Sharp, KW
    Pinson, W
    AMERICAN SURGEON, 2001, 67 (11) : 1041 - 1047
  • [26] Clinicopathological study of depth of subserosal invasion in patients with pT2 gallbladder carcinoma
    Sasaki, R
    Uesugi, N
    Itabashi, H
    Fujita, T
    Takeda, Y
    Hoshikawa, K
    Takahashi, M
    Funato, O
    Nitta, H
    Sugai, T
    Kanno, S
    Saito, K
    JOURNAL OF SURGICAL ONCOLOGY, 2005, 92 (02) : 83 - 88
  • [27] Patients with SM3-massive pT2 Gastric Cancer Have Worse Prognosis than Conventional pT2 Patients
    Kim, Hyunjin
    Ahn, Soomin
    Kim, Kyoung-Mee
    MODERN PATHOLOGY, 2022, 35 : 480 - 480
  • [28] Patients with SM3-massive pT2 Gastric Cancer Have Worse Prognosis than Conventional pT2 Patients
    Kim, Hyunjin
    Ahn, Soomin
    Kim, Kyoung-Mee
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 480 - 480
  • [29] Patients with SM3-massive pT2 Gastric Cancer Have Worse Prognosis than Conventional pT2 Patients
    Kim, Hyunjin
    Ahn, Soomin
    Kim, Kyoung-Mee
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 480 - 480
  • [30] Optimal Surgical Treatment for Patients with pT2 Gallbladder Cancer
    Harada, Kenichi
    Ochiai, Toshiya
    Inoue, Koji
    Soga, Koji
    Murayama, Yasutoshi
    Komatsu, Shuhei
    Shiozaki, Atsushi
    Kuriu, Yoshiaki
    Ikoma, Hisashi
    Nakanishi, Masayoshi
    Ichikawa, Daisuke
    Fujiwara, Hitoshi
    Okamoto, Kazuma
    Kokuba, Yukihito
    Sonoyama, Teruhisa
    Otsuji, Eigo
    HEPATO-GASTROENTEROLOGY, 2011, 58 (105) : 14 - 19